Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
73 hedge funds and large institutions have $274M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 1 closing their positions.
1,100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 1
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
30% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 23
23% more capital invested
Capital invested by funds: $223M → $274M (+$51.2M)
18% more funds holding
Funds holding: 62 → 73 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$4.31M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$3.79M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$3.36M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.31M |
| 5 |
DM
Deerfield Management
New York
|
+$908K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
-$13.9M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.34M |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$562K |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$394K |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$339K |
OXFD Hedge Fund Activity: Q4 2016 in Review
73 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2016, worth a combined $274M — up 23% from $223M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new OXFD positions and 1 closed out — a net gain of 11 holders — while 30 added to existing stakes and 23 trimmed.
The largest buyer was RTW Investments, adding an estimated $4.31M. The largest seller was Clarus Ventures, cutting an estimated $13.9M.
- 73 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2016, up from 62 in Q3 2016.
- Funds reported $274M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2016, up 23% quarter-over-quarter.
- 12 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2016 and 1 closed out, a net change of +11 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2016 was RTW Investments, an estimated $4.31M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2016 was Clarus Ventures, an estimated $13.9M sold.
Based on aggregated 13F filings for Q4 2016.